A RANDOMIZED PHASE II STUDY OF PREOPERATIVE CISPLATIN VS PACLITAXEL IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER

Administered By

Awarded By

Contributors

Start/End

  • October 1, 2014 - April 30, 2020